ELEMIS ANNOUNCES STATUS AS A CERTIFIED B CORP
THE WHAT? L’Occitane-owned Elemis has announced its status as a Certified B Corp.
THE DETAILS According to a press release, the brand has spent two years implementing changes to processes, practices and launching new initiatives across the business and has achieved 93 points.
THE WHY? The certification highlights Elemis’ ESG push and to be an eco-conscious brand.
André Hoffman, Vice-Chairman and CEO of the L’OCCITANE Group, said: “This achievement is a testament to the commitment of the brand’s teams across all levels and to the positive impact that ELEMIS has made on the beauty industry since it was founded over 30 years ago.
“This is the first milestone on our Group’s ambitious journey towards global B Corp Certification. It proves that a clear, collective focus on the triple bottom line – our people, the planet and profitability – is possible for a company of our size.”
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
Venator Launches TMP- and TME-Free Titanium Dioxide
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
Recommend Reading
-
India Targets Fake Drug Packaging
-
India’s Pharma Cost Problem Gets Worse
-
US Slaps 50% Tariff on Brazilian Coffee Honduras Eyes $430 Million Export Boom
-
Tatarstan’s Agri Exports to China Surge to 13.5% in 2025 First Half Value Hits $1.05 Billion
-
“Did They Just Buy a Money Printer for ¥288 Million?”: Yip’s Chemical’s Bold Bet on Green Tech—Is This a Genuine Transformation or Just Another Story for the Stock Market?
-
This Week's PVC Prices Narrowly Declined in China
-
2026 Week 19 Commodity Weekly Report: Chemicals Lead Decline, Energy and Non-ferrous Metals Show Strength in Some Areas
-
This Week China's Titanium Dioxide Market Prices Stabilize (5.11-5.15)
-
This Week, the Chinese Polymeric MDI Market Rebounded and Rose (5.11-5.15)
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI